# Accendra Health Inc. (ACH)

Source: https://www.quantisnow.com/company/ACH
Generated: 2026-11-01T00:51:13.675Z

- Ticker: ACH
- Exchange: NYSE
- Sector: Health Care
- Industry: Medical Specialities
- SEC CIK: 0000075252
- Website: chalco.com.cn

## About

Aluminum Corporation of China Limited, together with its subsidiaries, manufactures and sells alumina, primary aluminum, and energy products in the People's Republic of China. The company operates through Alumina, Primary Aluminum, Trading, and Energy segments. The Alumina segment mines for and purchases bauxite and other raw materials; and produces and sells alumina, as well as refined alumina. The Primary Aluminum segment procures alumina and other raw materials, supplemental materials, and electrical power; and produces and sells aluminum and aluminum-related products, such as carbon, aluminum alloy, and other electrolytic aluminum products. The Trading segment trades in alumina, primary aluminum, aluminum fabrication products, other non-ferrous metal products, coal products, raw and supplemental materials; and provides logistics and transport services to external customers. The Energy segment engages in coal mining; and generates and sells electricity using thermal power, wind power, and solar power sources to regional power grid corporations, as well as manufactures power related equipment. The company also acquires, manufactures, and distributes bauxite mines and limestone ore; and provides engineering project management, and research and development services. Aluminum Corporation of China Limited was incorporated in 2001 and is headquartered in Beijing, the People's Republic of China.

## Latest ACH news and filings

- 2026-10-30 20:50 UTC [SEC Form 8-K] [SEC Form 8-K filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-accendra-health-inc-6765480)
- 2026-10-30 20:45 UTC [Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard​](https://www.quantisnow.com/insight/accendra-health-receives-continued-listing-standard-notice-from-nyse-regarding-6765461)
- 2026-10-29 20:15 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-accendra-health-inc-6763690)
- 2026-10-22 20:05 UTC [Earnings Date] [Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call](https://www.quantisnow.com/insight/accendra-health-announces-third-quarter-2026-earnings-release-date-and-6755004)
- 2026-10-19 21:16 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-accendra-health-inc-6750969)
- 2026-10-09 20:10 UTC [SEC Form 8-K] [SEC Form 8-K filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-accendra-health-inc-6742898)
- 2026-10-09 20:05 UTC [Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard](https://www.quantisnow.com/insight/accendra-health-receives-continued-listing-standard-notice-from-nyse-intends-6742803)
- 2026-10-07 15:28 UTC [SEC Form SCHEDULE 13G filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-accendra-health-inc-6740076)
- 2026-10-07 00:15 UTC [SEC Form 4] [SEC Form 4 filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-accendra-health-inc-6739461)
- 2026-09-28 21:06 UTC [SEC Form 8-K] [Amendment: Accendra Health Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-accendra-health-inc-filed-sec-form-8-k-leadership-update-6728007)
- 2026-09-24 20:31 UTC [SEC Form 4] [EVP & CFO Leon Jonathan A covered exercise/tax liability with 4,265 shares, decreasing direct ownership by 1% to 286,268 units (SEC Form 4) (for withholding tax)](https://www.quantisnow.com/insight/evp-cfo-leon-jonathan-a-covered-exercisetax-liability-with-4265-6725588)
- 2026-09-17 10:35 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-leadership-update-regulation-6718320)
- 2026-09-17 10:30 UTC [Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth](https://www.quantisnow.com/insight/accendra-health-names-kenneth-gardner-smith-as-president-and-chief-executive-6718310)
- 2026-08-17 10:42 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-regulation-fd-disclosure-6684131)
- 2026-08-17 10:30 UTC [Leadership Update] [Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans](https://www.quantisnow.com/insight/accendra-health-updates-on-capital-allocation-and-ceo-succession-timing-6684114)
- 2026-08-11 12:42 UTC [Analyst Downgrade] [Accendra Health downgraded by Citigroup with a new price target](https://www.quantisnow.com/insight/accendra-health-downgraded-by-citigroup-with-a-new-price-target-6675144)
- 2026-08-11 12:42 UTC [Analyst Downgrade] [Accendra Health downgraded by Robert W. Baird with a new price target](https://www.quantisnow.com/insight/accendra-health-downgraded-by-robert-w-baird-with-a-new-6675143)
- 2026-08-10 20:20 UTC [SEC Form 8-A12B filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-8-a12b-filed-by-accendra-health-inc-6673891)
- 2026-08-10 20:15 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-entry-into-a-6673806)
- 2026-08-10 15:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-accendra-health-inc-6673216)
- 2026-08-10 10:50 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-results-of-operations-6672542)
- 2026-08-10 10:50 UTC [Earnings Date] [Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value](https://www.quantisnow.com/insight/accendra-health-announces-adoption-of-tax-asset-preservation-plan-to-6672540)
- 2026-08-10 10:45 UTC [Earnings Date] [Accendra Health Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/accendra-health-reports-second-quarter-2026-financial-results-6672529)
- 2026-08-10 10:36 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-leadership-update-regulation-6672522)
- 2026-08-10 10:30 UTC [Earnings Date] [Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search](https://www.quantisnow.com/insight/accendra-healths-ed-pesicka-announces-intent-to-retire-board-of-6672509)
- 2026-07-27 20:05 UTC [Accendra Health Announces Leadership Appointments in IT and Procurement](https://www.quantisnow.com/insight/accendra-health-announces-leadership-appointments-in-it-and-procurement-6649590)
- 2026-07-27 13:15 UTC [Earnings Date] [Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call](https://www.quantisnow.com/insight/accendra-health-announces-second-quarter-2026-earnings-release-date-and-6649299)
- 2026-07-27 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-accendra-health-inc-6648828)
- 2026-07-15 20:15 UTC [SEC Form S-3] [SEC Form S-3 filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-accendra-health-inc-6638362)
- 2026-06-25 20:15 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-other-events-6615873)
- 2026-06-24 01:15 UTC [Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations](https://www.quantisnow.com/insight/accendra-health-announces-expiration-and-final-results-of-offers-and-6613342)
- 2026-06-15 20:15 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-entry-into-a-6602644)
- 2026-06-10 10:30 UTC [Conference Announcement] [Accendra Health Announces Early Results of Offers and Consent Solicitations](https://www.quantisnow.com/insight/accendra-health-announces-early-results-of-offers-and-consent-solicitations-6596271)
- 2026-05-29 12:30 UTC [SEC Form SD filed by Accendra Health Inc.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-accendra-health-inc-6578488)
- 2026-05-22 20:08 UTC [SEC Form 8-K] [Accendra Health Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/accendra-health-inc-filed-sec-form-8-k-regulation-fd-disclosure-6569699)
- 2026-05-22 20:01 UTC [Conference Announcement] [Accendra Health Announces Offers and Consent Solicitations](https://www.quantisnow.com/insight/accendra-health-announces-offers-and-consent-solicitations-6569456)
- 2026-05-20 12:31 UTC [SEC Form 4] [EVP,General Counsel & CorpSecy Galloway Heath H covered exercise/tax liability with 1,822 shares, decreasing direct ownership by 1% to 166,306 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/evpgeneral-counsel-corpsecy-galloway-heath-h-covered-exercisetax-liability-with-6564481)
- 2026-05-19 12:55 UTC [SEC Form 4] [EVP & CFO Leon Jonathan A covered exercise/tax liability with 1,770 shares, decreasing direct ownership by 0.61% to 290,533 units (SEC Form 4) to cover withholding tax](https://www.quantisnow.com/insight/evp-cfo-leon-jonathan-a-covered-exercisetax-liability-with-1770-6561927)
- 2026-05-19 12:54 UTC [SEC Form 4] [President & CEO Pesicka Edward A covered exercise/tax liability with 17,692 shares, decreasing direct ownership by 2% to 1,072,785 units (SEC Form 4) to satisfy withholding obligation](https://www.quantisnow.com/insight/president-ceo-pesicka-edward-a-covered-exercisetax-liability-with-17692-6561925)
- 2026-05-19 12:54 UTC [SEC Form 4] [EVP,General Counsel & CorpSecy Galloway Heath H covered exercise/tax liability with 966 shares, decreasing direct ownership by 0.57% to 168,128 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/evpgeneral-counsel-corpsecy-galloway-heath-h-covered-exercisetax-liability-with-6561919)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ACH
- RSS and alerts for ACH: https://www.quantisnow.com/docs/rss-feeds.md